Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

      August 21, 2026
      Research & Development

      Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

      August 18, 2026
      Research & Development

      Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

      July 22, 2026
      Research & Development

      ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

      July 20, 2026
  • Clinical
    • Clinical

      Mirum’s Brelovitug Meets Main Goal in Phase 3 Chronic Hepatitis Delta Trial

      September 29, 2026
      Clinical

      Best-in-disease ambitions are fueled by Roche’s GLP-1/GIP medication’s success in a phase 2 diabetic trial

      September 25, 2026
      Clinical

      Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Misses Primary Endpoint

      September 25, 2026
      Clinical

      Bristol Myers Squibb Ends Development of Orum’s ORM-6151 After Phase 1 Review

      September 22, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Novo and Lilly Trade New GLP-1 Data at Major Diabetes Meeting

      October 1, 2026
      Commercial

      Merck Signs Huge Deal With SciBrunch For KRAS G12D

      September 29, 2026
      Commercial

      Life Sciences Voice In Collaboration With Future Pharma EU 2026

      September 25, 2026
  • Technology
    • Technology

      Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

      August 30, 2026
      Technology

      Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

      August 5, 2026
      Technology

      J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

      July 22, 2026
      Technology

      Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

      June 9, 2026
  • Insights
    • Insights

      How AI Agents Will Transform Medical Information

      September 25, 2026
      Insights

      Robotics in Pharmaceutical R&D

      September 25, 2026
      Insights

      Top 10 Ways AI Is Reducing Drug Commercialization Costs

      September 25, 2026
      Insights

      Top 10 Technologies Supporting Multi-Omics Research

      September 25, 2026
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
X
Home Tags Cerebral

Tag: cerebral

Ingrezza
Clinical

Phase 3 of Neurocrine’s Ingrezza cerebral palsy trial unsuccessful

Editorial Team -
January 3, 2026
0

Editor Picks

Teva Secures $100M Funding to Expedite Schizophrenia Drug Development

November 15, 2023

CellCentric Secures $120M Series C Funding to Advance Myeloma Drug Inobrodib

May 22, 2025

AstraZeneca receives approval for blood pressure medication

May 20, 2026

Must Read

White House Seeks U.S. Manufacturing Capacity for 86 Essential Medicines

October 1, 2026

Novo and Lilly Trade New GLP-1 Data at Major Diabetes Meeting

October 1, 2026

EU Withdraws Hansoh’s Aumseqa Authorization After AstraZeneca Challenge

October 1, 2026

Hot Topics

  • Clinical512
  • Commercial451
  • Regulatory359
  • Insights183
  • Research & Development112
  • Manufacturing101
  • Newsletter59
  • Technology44
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
X

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial